SK5322000A3 - Use of thiazolidinediones for the treatment of hyperglycaemia - Google Patents

Use of thiazolidinediones for the treatment of hyperglycaemia Download PDF

Info

Publication number
SK5322000A3
SK5322000A3 SK532-2000A SK5322000A SK5322000A3 SK 5322000 A3 SK5322000 A3 SK 5322000A3 SK 5322000 A SK5322000 A SK 5322000A SK 5322000 A3 SK5322000 A3 SK 5322000A3
Authority
SK
Slovakia
Prior art keywords
hyperglycemia
glucose levels
plasma glucose
compound
range
Prior art date
Application number
SK532-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK5322000A3 publication Critical patent/SK5322000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK532-2000A 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia SK5322000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721692.3A GB9721692D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003067 WO1999018944A1 (fr) 1997-10-13 1998-10-12 Utilisation de thiazolidinediones pour le traitement de l'hyperglycemie

Publications (1)

Publication Number Publication Date
SK5322000A3 true SK5322000A3 (en) 2000-09-12

Family

ID=10820481

Family Applications (1)

Application Number Title Priority Date Filing Date
SK532-2000A SK5322000A3 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Country Status (24)

Country Link
EP (1) EP1023057A1 (fr)
JP (1) JP2001519383A (fr)
KR (1) KR20010024482A (fr)
CN (1) CN1281358A (fr)
AP (1) AP1223A (fr)
AU (1) AU9547198A (fr)
BG (1) BG104405A (fr)
BR (1) BR9815220A (fr)
CA (1) CA2305289A1 (fr)
CZ (1) CZ20001298A3 (fr)
EA (1) EA200000418A1 (fr)
GB (1) GB9721692D0 (fr)
HR (1) HRP20000256A2 (fr)
HU (1) HUP0003673A3 (fr)
ID (1) ID24439A (fr)
IL (1) IL135515A0 (fr)
NO (1) NO20001897L (fr)
OA (1) OA11519A (fr)
PL (1) PL339804A1 (fr)
SK (1) SK5322000A3 (fr)
TR (1) TR200000957T2 (fr)
UA (1) UA66809C2 (fr)
WO (1) WO1999018944A1 (fr)
YU (1) YU28700A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2001002036A0 (en) * 1998-07-21 2001-03-31 Smithkline Beecham Plc Use of glucose uptake enhancer for reducing apoptosis.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (fr) * 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
CN1281358A (zh) 2001-01-24
YU28700A (sh) 2003-10-31
CZ20001298A3 (cs) 2001-08-15
IL135515A0 (en) 2001-05-20
AP2000001788A0 (en) 2000-06-30
HRP20000256A2 (en) 2000-12-31
TR200000957T2 (tr) 2000-08-21
PL339804A1 (en) 2001-01-02
EA200000418A1 (ru) 2000-10-30
AU9547198A (en) 1999-05-03
NO20001897L (no) 2000-06-09
KR20010024482A (ko) 2001-03-26
WO1999018944A1 (fr) 1999-04-22
HUP0003673A3 (en) 2001-12-28
AP1223A (en) 2003-11-13
ID24439A (id) 2000-07-20
BG104405A (en) 2000-12-29
HUP0003673A2 (hu) 2001-10-28
NO20001897D0 (no) 2000-04-12
CA2305289A1 (fr) 1999-04-22
UA66809C2 (uk) 2004-06-15
JP2001519383A (ja) 2001-10-23
BR9815220A (pt) 2000-11-14
GB9721692D0 (en) 1997-12-10
EP1023057A1 (fr) 2000-08-02
OA11519A (en) 2004-02-09

Similar Documents

Publication Publication Date Title
KR100666591B1 (ko) 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료
KR100671918B1 (ko) 티아졸리딘디온, 인슐린 분비촉진제 및 디구아니드를사용한 당뇨병의 치료
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
SK179499A3 (en) The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent
US20020006939A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
SK5322000A3 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
US20010031776A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
SK5312000A3 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA00003634A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA00003633A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
AU4587002A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
AU4586902A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA99012078A (en) Treatment of diabetes with thiazolidinedione and metformin
MXPA99012098A (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
UA68352C2 (en) Method for treatment of diabetes mellitus with thiazolidin and metformin